Basic Information
| LncRNA/CircRNA Name | LINC01296 |
| Synonyms | DUXAP9, LINC01296, FLJ39632, lncRNA-CTD903 |
| Region | GRCh38_14:19062316-19131167 |
| Ensemble | ENSG00000225210 |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | bladder cancer |
| ICD-0-3 | C67 |
| Methods | Microarray, qPCR, RIP etc. |
| Sample | cell lines (RT4, HT1376, HT1197, T24, J82, UMUC3, SLT4, FL3, LUL2) |
| Expression Pattern | up-regulated |
| Function Description | The lincRNAs LINC00958 and LINC01296 were signifcantly up-regulated and displayed phenotypic functions indicative of oncogenic properties in BC. Te oncogenic function of LINC00958 is likely associated with RNA binding proteins including MTDH by yet undefned mechanisms. |
| Pubmed ID | 29059779 |
| Year | 2017 |
| Title | Profling of long non-coding RNAs identifes LINC00958 and LINC01296 as candidate oncogenes in bladder cancer |
External Links
| Links for LINC01296 | GenBank HGNC NONCODE |
| Links for bladder cancer | OMIM COSMIC |